Parabilis Medicines, Inc. (PBLS)
30.37
+1.84
(+6.45%)
USD |
NASDAQ |
Nov 09, 16:00
29.77
-0.60
(-1.98%)
After-Hours: 20:00
Parabilis Medicines Total Liabilities (Quarterly) : 127.53M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 127.53M |
| Date | Value |
|---|---|
| March 31, 2026 | 139.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.637B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.175B |
| Shareholders Equity (Quarterly) | 1.048B |
| Debt to Equity Ratio | 0.0453 |
| Current Ratio | 17.91 |
| Net Debt Paydown Yield | -0.22% |